Esperas Pharma Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 2

Esperas Pharma General Information

Description

Operator of a medical technology platform intended to offer biopharmaceutical products. The company's platform engages in developing an oral investigational medicine which specifically inhibits cancer cell division or unchecked proliferation, enabling healthcare professionals to avail a number of additional cancer indications with the goal of providing a clinical proof-of-concept of efficacy for cancer patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 810-1470 rue Peel
  • Montreal, Quebec H3A 1T1
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Esperas Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 21-Feb-2023 000.00 Completed Clinical Trials - Phase 1
1. Early Stage VC 13-Apr-2015 000.00 000.00 Completed Startup
To view Esperas Pharma’s complete valuation and funding history, request access »

Esperas Pharma Executive Team (3)

Name Title Board Seat Contact Info
Caroline Fortier Ph.D Chief Executive Officer
Chantal Miklosi Chief Financial Officer
You’re viewing 2 of 3 executive team members. Get the full list »

Esperas Pharma Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Fonds de solidarite FTQ PE/Buyout Minority 000 0000 000000 0
TVM Capital Life Science Venture Capital Minority 000 0000 000000 0
To view Esperas Pharma’s complete investors history, request access »

Esperas Pharma FAQs

  • When was Esperas Pharma founded?

    Esperas Pharma was founded in 2015.

  • Who is the CEO of Esperas Pharma?

    Caroline Fortier Ph.D is the CEO of Esperas Pharma.

  • Where is Esperas Pharma headquartered?

    Esperas Pharma is headquartered in Montreal, Canada.

  • What industry is Esperas Pharma in?

    Esperas Pharma’s primary industry is Biotechnology.

  • Is Esperas Pharma a private or public company?

    Esperas Pharma is a Private company.

  • What is Esperas Pharma’s current revenue?

    The current revenue for Esperas Pharma is 000000.

  • How much funding has Esperas Pharma raised over time?

    Esperas Pharma has raised $16.5M.

  • Who are Esperas Pharma’s investors?

    Fonds de solidarite FTQ and TVM Capital Life Science have invested in Esperas Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »